Value Research Rating

3 star

Quality Score fund-quick-summary-circle

0/0

Growth Score fund-quick-summary-circle

0/0

Valuation Score fund-quick-summary-circle

0/0

Momentum Score fund-quick-summary-circle

0/0

Aurobindo Pharma Ltd. Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 1,081.00 High: 1,103.00

52 Week Range

Low: 1,010.00 High: 1,592.00

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Market capMarket cap information

    ₹63,641 Cr

  • Revenue (TTM)Revenue (TTM) information

    ₹31,724 Cr

  • Net Profit (TTM)Net Profit (TTM) information

    ₹3,486 Cr

  • ROEROE information

    11.2 %

  • ROCEROCE information

    13.8 %

  • P/E RatioP/E Ratio information

    18.3

  • P/B RatioP/B Ratio information

    1.9

  • Industry P/EIndustry P/E information

    36.17

  • EV/EBITDAEV/EBITDA information

    8.8

  • Div. YieldDiv. Yield information

    0 %

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹562.2

  • EPSEPS information

    ₹59.9

  • Face valueFace value information

    1

  • Shares outstandingShares outstanding information

    580,801,623

10 Years Aggregate

CFO

₹27,088.72 Cr

EBITDA

₹41,053.60 Cr

Net Profit

₹26,604.69 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Aurobindo Pharma
-17.8 -9.0 -5.7 -10.2 28.6 7.0 4.9
BSE Sensex
5.3 0.4 9.2 6.6 17.1 18.9 11.7
BSE Healthcare
-4.6 0.9 5.1 17.0 27.1 21.6 10.3
As on 20-Jun-2025
Company
2024
2023
2022
2021
2020
2019
2018
Aurobindo Pharma
23.5 147.3 -40.3 -20.8 101.1 -37.7 7.2
BSE Sensex
8.1 18.7 4.4 22.0 15.8 14.4 5.9
BSE Healthcare
43.1 37.0 -12.1 20.9 61.4 -3.5 -5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Aurobindo Pharma
1,097.2 63,641.3 31,723.7 3,515.3 15.5 11 18.3 1.9
31,620.0 67,254.0 6,409.2 1,414.4 25.3 36.5 47.5 15.9
4,773.5 57,203.5 12,964.5 2,216.0 16.6 18.4 26.4 4.8
1,499.7 1,21,196.6 27,547.6 5,291.1 21.9 17.7 23 3.9
1,325.3 1,10,618.2 32,643.9 5,703.5 20.7 17.6 19.6 3.3
1,948.0 88,507.6 22,707.9 3,306.3 18.0 20 27 5.1
2,288.8 94,578.9 12,279.3 1,998.9 19.6 16 47.5 6.6
1,665.1 3,99,249.3 52,578.4 10,980.1 23.3 16.2 36.5 5.5
3,167.2 1,07,539.4 11,516.0 1,911.0 25.4 25.6 56.3 14.2
957.1 96,075.2 23,241.5 4,614.8 26.2 20.4 21.2 4.0

Shareholding Pattern

View Details
loading...

News & Analysis

All News

About Aurobindo Pharma Ltd.

Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and...  over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.  Read more

  • Incorporated

    1986

  • Chairman

    M Ramasubramanian

  • Managing Director

    K Nithyananda Reddy

  • Group

    Aurobindo

  • Headquarters

    Hyderabad, Telangana

  • Website

    www.aurobindo.com

Edit peer-selector-edit

Quarterly Updates

FAQs for Aurobindo Pharma Ltd.

The total asset value of Aurobindo Pharma Ltd stood at ₹ 49,785 Cr as on 31-Mar-25

The share price of Aurobindo Pharma Ltd is ₹1,097.20 (NSE) and ₹1,096.20 (BSE) as of 20-Jun-2025 IST. Aurobindo Pharma Ltd has given a return of 28.61% in the last 3 years.

Aurobindo Pharma Ltd has a market capitalisation of ₹ 63,641 Cr as on 20-Jun-2025. As per Value Research classification, it is a Large Cap company.

The P/B ratio of Aurobindo Pharma Ltd is 1.95 times as on 20-Jun-2025, a 62% discount to its peers’ median range of 5.13 times.

The P/E ratio of Aurobindo Pharma Ltd is 18.26 times as on 20-Jun-2025, a 50% discount to its peers’ median range of 36.17 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Aurobindo Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Aurobindo Pharma Ltd.

Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

The prominent promoters of Aurobindo Pharma Ltd. are

Name of promoters Holding percentage

RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING)

33.5%

KAMBAM NITYANANDA REDDY

4.37%

KIRTHI REDDY KAMBAM

3.45%
Click here to see the full list

The chairman of the company is M Ramasubramanian, and the managing director is K Nithyananda Reddy.

The promoters of Aurobindo Pharma Ltd have pledged 8.77% of the total equity as on Mar-25.

Some of the close peers are:

Company Market Cap(₹ Cr)
4,05,176
1,21,592
1,13,615
1,10,024
98,310
98,108
91,355
67,031
57,966
Aurobindo Pharma Ltd. Ratios
Return on equity(%)
10.97
Operating margin(%)
15.47
Net Margin(%)
10.86
Dividend yield(%)
0

Yes, TTM profit after tax of Aurobindo Pharma Ltd was ₹3,486 Cr.